A lot what gets posted here on FR comes from sources like The Expose. I think that’s what you are referring to.
PubMed is where serious studies get published and open to peer review. Such as this paper from July 2021:
Ivermectin for preventing and treating COVID-19
Objectives: To assess the efficacy and safety of ivermectin compared to no treatment, standard of care, placebo, or any other proven intervention for people with COVID-19 receiving treatment as inpatients or outpatients, and for prevention of an infection with SARS-CoV-2 (postexposure prophylaxis).
Main results: We found 14 studies with 1678 participants investigating ivermectin compared to no treatment, placebo, or standard of care.
No study compared ivermectin to an intervention with proven efficacy.
There were nine studies treating participants with moderate COVID-19 in inpatient settings and four treating mild COVID-19 cases in outpatient settings.
One study investigated ivermectin for prevention of SARS-CoV-2 infection.
Eight studies had an open-label design, six were double-blind and placebo-controlled.
Of the 41 study results contributed by included studies, about one third were at overall high risk of bias.
Ivermectin doses and treatment duration varied among included studies. We identified 31 ongoing and 18 studies awaiting classification until publication of results or clarification of inconsistencies.
Ivermectin compared to placebo or standard of care for inpatient COVID-19 treatment
We are uncertain whether ivermectin compared to placebo or standard of care reduces or increases mortality and clinical worsening up to day 28 assessed as need for invasive mechanical ventilation (IMV) or need for supplemental oxygen, adverse events within 28 days, and viral clearance at day seven.
Ivermectin may have little or no effect compared to placebo or standard of care on clinical improvement up to 28 days and duration of hospitalization. No study reported quality of life up to 28 days.
Ivermectin compared to placebo or standard of care for outpatient COVID-19 treatment
We are uncertain whether ivermectin compared to placebo or standard of care reduces or increases mortality up to 28 days and clinical worsening up to 14 days assessed as need for IMV or non-IMV or high flow oxygen requirement.
We are uncertain whether ivermectin compared to placebo reduces or increases viral clearance at seven days . Ivermectin may have little or no effect compared to placebo or standard of care on the number of participants with symptoms resolved up to 14 days and adverse events within 28 days.
None of the studies reporting duration of symptoms were eligible for primary analysis. No study reported hospital admission or quality of life up to 14 days.
Ivermectin compared to no treatment for prevention of SARS-CoV-2 infection. We found one study. Mortality up to 28 days was the only outcome eligible for primary analysis.
We are uncertain whether ivermectin reduces or increases mortality compared to no treatment. The study reported results for development of COVID-19 symptoms and adverse events up to 14 days that were included in a secondary analysis due to high risk of bias. No study reported SARS-CoV-2 infection, hospital admission, and quality of life up to 14 days.
Authors’ conclusions: Based on the current very low- to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19. The completed studies are small and few are considered high quality. Several studies are underway that may produce clearer answers in review updates. Overall, the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID-19 outside of well-designed randomized trials.
https://pubmed.ncbi.nlm.nih.gov/34318930/
Read later pubmed.com info about ivermectin.
A lot what gets posted here on FR comes from sources like The Expose. I think that’s what you are referring to.
Only, no....MOST info, here, on Ivermectin doesn’t ‘come only from ‘The Expose’.
A very simple search, just using the keyword “Ivermectin” proves that....
https://freerepublic.com/tag/ivermectin/index?tab=articles
And....
Ivermectin, ‘Wonder drug’ from Japan: the human use perspective
www.ncbi.nlm.nih.gov ^ | February 10, 2011 | Andy CRUMP*1 and Satoshi ŌMURA*1†
Posted on 11/1/2021, 7:23:06 PM by ransomnote
https://freerepublic.com/focus/f-chat/4008875/posts
Just a few examples.
What I was referring to is how it is interesting to see you posting information about Ivm’s invention.....even though, as you can see, above, it’s been posted numerous times, before (and, not *just from* The Expose....many medical org sources, etc. as well.)